| Latest risk assessment |
 |
Paediatric inflammatory multisystem syndrome and SARS -CoV-2 infection in children Date of publication: 15 May 2020 Several countries affected by the coronavirus disease (COVID-19) pandemic recently reported cases of children that were hospitalised in intensive care due to a rare paediatric inflammatory multisystem syndrome (PIMS). The presenting signs and symptoms are a mix of the ones for Kawasaki disease (KD) and toxic shock syndrome (TSS) and are characterised, among others, by fever, abdominal pain and cardiac involvement.
|
| Technical reports on COVID-19 |
 |
Contact tracing for COVID-19: current evidence, options for scale-up and an assessment of resources needed Date of publication: 5 May 2020 This document outlines a number of resource measures including the use of well-trained non-public-health staff and volunteers; repurposing existing resources such as call centres; reducing the intensity of contact follow-up and using new technologies such as contact management software and mobile apps.
|
 |
Infection prevention and control and preparedness for COVID-19 in healthcare settings – third update Date of publication: 13 May 2020 This document aims to provide guidance to EU/EEA healthcare facilities and healthcare providers on infection prevention and control (IPC) measures for the management of suspected and confirmed cases of COVID-19 infection in healthcare settings, including long-term care facilities.
|
|
 |
Surveillance of COVID-19 at long-term care facilities in the EU/EEA Date of publication: 19 May 2020 It is of paramount importance to be able to rapidly identify, assess and control COVID-19 outbreaks in LTCFs in order to protect this particularly fragile population. This document provides guidance for EU/EEA Member States planning to implement monitoring systems at LTCFs and describes the surveillance objectives.
|
|
 |
COVID-19 Aviation Health Safety Protocol: Guidance for the management of airline passengers in relation to the COVID-19 pandemic Date of publication: 20 May 2020 EASA and ECDC have developed the following guidelines. Their purpose is to serve as an aviation health safety protocol and to provide a source of best practice on how airport operators, aeroplane operators conducting commercial and non-commercial passenger transport operations and national aviation authorities can ensure the health and safety of passengers, as well as the staff and crew who serve them, by maintaining safe and secure operations whilst minimising the risk of virus transmission.
|
|
 |
Projected baselines of COVID-19 in the EU/EEA and the UK for assessing the impact of de-escalation of measures Date of publication: 26 May 2020 This report aims to provide a short-term 30-day forecast of the expected number of COVID-19 cases, deaths and hospitalised cases (including general hospital ward and intensive care unit) under a set of assumptions.
|
|
 |
Considerations for travel-related measures to reduce spread of COVID-19 in the EU/EEA Date of publication: 26 May 2020 This document outlines principles for developing more individualised guidance or operating procedures related to travel in European countries.
|
|
 |
Methodology for estimating point prevalence of SARS-CoV-2 infection by pooled RT-PCR testing Date of publication: 28 May 2020 The scope of this document is to provide EU/EEA Member States and the UK with technical guidance for estimating the prevalence of SARS-CoV-2 infected cases, through a cross sectional study design based on pooled sampling for RT-PCR testing on a random population sample.
|
|
| Technical reports on other topics |
 |
HIV Combination prevention: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2018 progress report) Date of publication: 15 May 2020 HIV combination prevention is an approach that brings together single prevention initiatives into a comprehensive programme. In this report we present and test the feasibility of a novel approach to monitoring the implementation of combination HIV prevention at national level.
|
 |
Monitoring the responses to hepatitis B and C epidemics in the EU/EEA Member States, 2019 Date of publication: 19 May 2020 This report provides the first collation of data relating to the monitoring of the progress towards the elimination of hepatitis B and C for EU/EEA countries. Data were collated from a range of existing sources pertaining to epidemiological context, prevention and control, and impact. Data were also collected directly from all Member States on testing and treatment indicators for the continuum of care in relation to hepatitis B and C.
|
|
 |
Third external quality assessment on antimicrobial susceptibility testing and detection of ESBL-, acquired AmpC-, and carbapenemase-production of Salmonella, 2017 Date of publication: 29 May 2020 This report presents the results of the third round of the external quality assessment (EQA) on antimicrobial susceptibility testing (AST) for national public health laboratories on Salmonella (hereafter Salmonella EQA3-AST). The Salmonella EQA3-AST covered testing of antimicrobial susceptibility and detection and confirmation of ESBL-, acquired AmpC-, and carbapenemase-producing Salmonella.
|
|
| Surveillance reports |
 |
Influenza virus characterisation, April 2020 Date of publication: 13 May 2020 As of week 13/2020, 160 614 influenza detections across the WHO European Region ha have been reported; 73 % type A viruses, with A(H1N1 H1N1)pdm09 prevailing over A(H3N2) H3N2), and 27 % type B viruses, with 4 358 (98%) of 4 44 445 ascribed to a lineage being B/Victoria.
|
 |
Gonococcal antimicrobial susceptibility surveillance in Europe, 2018 Date of publication: 20 May 2020 The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC) since 2009. This surveillance is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform treatment guidelines.
|
|
 |
Annual Epidemiological Report series on communicable diseases in Europe Date of publication: released as new disease chapters become available The Annual Epidemiological Report series on communicable diseases in Europe provides a comprehensive summary of surveillance data for EU/EEA countries. It is mainly intended for public health professionals and policymakers involved in infectious disease prevention and control.
Published in May: |
|
 |
ECDC communicable disease threats report Date of publication: every Friday The ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control. Summarising information gathered by ECDC through its epidemic intelligence activities regarding communicable disease threats of concern to the European Union, it also provides updates on the global situation and changes in the epidemiology of communicable diseases with potential to affect Europe, including diseases that are the focus of eradication efforts.
|
|
| Scientific peer-reviewed publications |
 |
Publications by ECDC staff in scientific journals All scientific peer-reviewed publications produced by ECDC staff on behalf of the Centre for the period January 2005 – December 2019 are available online. |